Efficacy and safety of vitamin D as adjuvant therapy for childhood pneumonia: a Meta analysis.
- Author:
Shi-Yin MU
1
;
Ying-Xue ZOU
;
Jia ZHAI
;
Guo-Hua YAO
Author Information
1. Department of Pneumology, Tianjin Children's Hospital, Tianjin 300074, China. xue11235813@163.com.
- Publication Type:Journal Article
- From:
Chinese Journal of Contemporary Pediatrics
2020;22(2):124-129
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the efficacy and safety of vitamin D as an adjuvant therapy for childhood pneumonia through a systematic review.
METHODS:Cochrane Library, PubMed, EMbase, CNKI, Wanfang Data, and Weipu Data were searched for randomized controlled trials (RCTs) of vitamin D as the adjuvant therapy for childhood pneumonia published up to August 2019. Literature screening, quality assessment, and data extraction were performed based on inclusion and exclusion criteria. Revman 5.3 was used to perform the Meta analysis of outcome indicators.
RESULTS:A total of 7 RCTs with 1 527 children were included, with 762 children in the vitamin D adjuvant therapy group and 765 children in the control group. The results of the Meta analysis showed that vitamin D adjuvant therapy had no effect on recovery time (P=0.67), length of hospital stay (P=0.73), and time to relief of fever (P=0.43). Furthermore, it did not reduce the recurrence rate (P=0.14), rate of adverse events (P=0.20), and mortality rate (P=0.98) of childhood pneumonia.
CONCLUSIONS:Current evidence shows that vitamin D adjuvant therapy has no marked efficacy in the treatment of childhood pneumonia.
